Patents by Inventor Tamara Byk-Tennenbaum

Tamara Byk-Tennenbaum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABILIZED THROMBIN
    Publication number: 20220088156
    Abstract: The present invention is directed to compounds, methods for stabilizing thrombin activity with a thrombin binding oligonucleotide and to stabilized thrombin. The thrombin binding oligonucleotide is capable of inhibiting thrombin activity whereby the inhibition can be reversed with an antisense oligonucleotide.
    Type: Application
    Filed: December 10, 2021
    Publication date: March 24, 2022
    Inventors: Yair Pilpel, Sivan Doron, Yuri Zherdev, Tamara Byk-Tennenbaum
  • METHOD OF TREATING A DISEASE USING A GLYCOLYTIC DEPENDENT COMPOUND
    Publication number: 20220054527
    Abstract: Provided are implants and a glycolytic dependent compound for use in enhancing toxicity of the glycolytic dependent compound towards a cell, tissue and/or organ e.g., a diseased cell, tissue and/or organ, wherein the implant and the glycolytic dependent compound are contacted with the cell, tissue and/or organ in a non-blended form.
    Type: Application
    Filed: November 3, 2021
    Publication date: February 24, 2022
    Inventors: James Galloway, Tamara BYK-TENNENBAUM, Erez ILAN, Lior WEISSMAN, Sivan DORON, Eve MONTIA, Niels-Derrek Schmitz
  • Stabilized thrombin
    Patent number: 11229688
    Abstract: The present invention is directed to compounds, methods for stabilizing thrombin activity with a thrombin binding oligonucleotide and to stabilized thrombin. The thrombin binding oligonucleotide is capable of inhibiting thrombin activity whereby the inhibition can be reversed with an antisense oligonucleotide.
    Type: Grant
    Filed: October 22, 2018
    Date of Patent: January 25, 2022
    Assignee: Omrix Biopharmaceuticals Ltd.
    Inventors: Yair Pilpel, Sivan Doron, Yuri Zherdev, Tamara Byk-Tennenbaum
  • METHOD OF TREATING A DISEASE USING A GLYCOLYTIC DEPENDENT COMPOUND
    Publication number: 20210154224
    Abstract: Provided is a method of enhancing toxicity of a glycolytic dependent compound towards a cell, tissue and/or organ e.g. a diseased cell, tissue and/or organ, the method comprises contacting Oxidized Regenerated Cellulose (ORC) and/or Oxidized Cellulose (OC); and a glycolytic dependent compound with the cell, tissue and/or organ. The ORC and/or OC; and the glycolytic dependent compound are contacted with the cell, tissue and/or organ in a non-blended form.
    Type: Application
    Filed: February 4, 2021
    Publication date: May 27, 2021
    Inventors: James Galloway, Tamara BYK-TENNENBAUM, Erez ILAN, Lior WEISSMAN, Sivan DORON, Eve MONTIA
  • Method of treating a disease using a glycolytic dependent compound
    Patent number: 10960021
    Abstract: Provided is a method of enhancing toxicity of a glycolytic dependent compound towards a cell, tissue and/or organ e.g. a diseased cell, tissue and/or organ, the method comprises contacting Oxidized Regenerated Cellulose (ORC) and/or Oxidized Cellulose (OC); and a glycolytic dependent compound with the cell, tissue and/or organ. The ORC and/or OC; and the glycolytic dependent compound are contacted with the cell, tissue and/or organ in a non-blended form.
    Type: Grant
    Filed: August 11, 2016
    Date of Patent: March 30, 2021
    Assignees: Omrix Biopharmaceuticals Ltd., Ethicon, Inc.
    Inventors: James Galloway, Tamara Byk-Tennenbaum, Erez Ilan, Lior Weissman, Sivan Doron, Eve Montia
  • Modular apparatus for delivery of fluid materials
    Patent number: 10231720
    Abstract: Apparatuses and methods for delivery of fluid materials, particularly multi-part fluid materials, including modular apparatuses in which various components are maintained separately until ready for use. Each fluid component is maintained in a separate housing until mixing of the fluid components is desired. Maintaining components separately until use allows for proper filling, sterilization, packaging and storing until use.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: March 19, 2019
    Assignees: Ethicon, Inc., Omrix Biopharmaceuticals Ltd.
    Inventors: John Goodman, Jared Schneider, Kenneth M. Tamsula, Erez Ilan, Tamara Byk-Tennenbaum, John Anastasiadis
  • Stabilized Thrombin
    Publication number: 20190054156
    Abstract: The present invention is directed to compounds, methods for stabilizing thrombin activity with a thrombin binding oligonucleotide and to stabilized thrombin. The thrombin binding oligonucleotide is capable of inhibiting thrombin activity whereby the inhibition can be reversed with an antisense oligonucleotide.
    Type: Application
    Filed: October 22, 2018
    Publication date: February 21, 2019
    Inventors: Yair Pilpel, Sivan Doron, Yuri Zherdev, Tamara Byk-Tennenbaum
  • Kit with stabilized thrombin
    Patent number: 10159719
    Abstract: The present invention is directed to compounds, methods for stabilizing thrombin activity with a thrombin binding oligonucleotide and to stabilized thrombin. The thrombin binding oligonucleotide is capable of inhibiting thrombin activity whereby the inhibition can be reversed with an antisense oligonucleotide.
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: December 25, 2018
    Assignee: Omrix Biopharmaceuticals Ltd.
    Inventors: Yair Pilpel, Sivan Doron, Yuri Zherdev, Tamara Byk-Tennenbaum
  • Viral inactivated biological mixture
    Patent number: 9867852
    Abstract: The invention relates to a viral inactivated biological liquid or dry mixture and to its preparation. Principally, the invention relates, but is not limited, to a mixture derived from a platelet source.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: January 16, 2018
    Assignee: Omrix Biopharmaceuticals Ltd.
    Inventors: Lior Weissman, Itai Podoler, Israel Nur, Tamara Byk-Tennenbaum
  • VIRAL INACTIVATED BIOLOGICAL MIXTURE
    Publication number: 20170252372
    Abstract: The invention relates to a viral inactivated biological liquid or dry mixture and to its preparation. Principally, the invention relates, but is not limited, to a mixture derived from a platelet source.
    Type: Application
    Filed: May 17, 2017
    Publication date: September 7, 2017
    Inventors: Lior Weissman, Itai Podoler, Israel Nur, Tamara Byk-Tennenbaum
  • Modular Apparatus For Delivery of Fluid Materials
    Publication number: 20170042523
    Abstract: Apparatuses and methods for delivery of fluid materials, particularly multi-part fluid materials, including modular apparatuses in which various components are maintained separately until ready for use. Each fluid component is maintained in a separate housing until mixing of the fluid components is desired. Maintaining components separately until use allows for proper filling, sterilization, packaging and storing until use.
    Type: Application
    Filed: October 28, 2016
    Publication date: February 16, 2017
    Inventors: John Goodman, Jared Schneider, Kenneth M. Tamsula, Erez ILAN, Tamara Byk-Tennenbaum, John Anastasiadis
  • Modular Apparatus for Delivery of Fluid Materials
    Publication number: 20160067406
    Abstract: Apparatuses and methods for delivery of fluid materials, particularly multi-part fluid materials, including modular apparatuses in which various components are maintained separately until ready for use. Each fluid component is maintained in a separate housing until mixing of the fluid components is desired. Maintaining components separately until use allows for proper filling, sterilization, packaging and storing until use.
    Type: Application
    Filed: September 8, 2014
    Publication date: March 10, 2016
    Inventors: John Goodman, Jared Schneider, Kenneth M. Tamsula, Erez ILAN, Tamara Byk-Tennenbaum, John Anastasiadis
  • STABILIZED THROMBIN
    Publication number: 20160051641
    Abstract: The present invention is directed to compounds, methods for stabilizing thrombin activity with a thrombin binding oligonucleotide and to stabilized thrombin. The thrombin binding oligonucleotide is capable of inhibiting thrombin activity whereby the inhibition can be reversed with an antisense oligonucleotide.
    Type: Application
    Filed: August 20, 2015
    Publication date: February 25, 2016
    Inventors: Yair Pilpel, Sivan Doron, Yuri Zherdev, Tamara Byk-Tennenbaum
  • Viral Inactivated Biological Mixture
    Publication number: 20140179602
    Abstract: The invention relates to a viral inactivated biological liquid or dry mixture and to its preparation. Principally, the invention relates, but is not limited, to a mixture derived from a platelet source.
    Type: Application
    Filed: December 19, 2013
    Publication date: June 26, 2014
    Applicant: Omrix Biopharmaceuticals Ltd.
    Inventors: Lior Weissman, Itai Podoler, Israel Nur, Tamara Byk-Tennenbaum